Latest News about LEXX
Recent news which mentions LEXX
From Benzinga
From InvestorPlace
From Benzinga
Lexaria's DehydraTECH-CBD Diabetes Study Demonstrates Weight Loss, Improved Triglyceride And Cholesterol Levels
March 02, 2023
From Benzinga
From Benzinga
Lexaria Discovers Potential Novel Mechanism From Hypertension Study Of Processed CBD
February 21, 2023
Tickers
LEXX
From Benzinga
This BioTech Company Using CBD For Enhanced Hypertension Treatment Could Be One To Watch
November 07, 2022
Tickers
LEXX
From Benzinga
Recap Of Wednesday's Biotech Catalysts - End Of the Day Summary
August 10, 2022
From Benzinga
Lexaria Gets FDA's Positive Feedback On Pre-Clinical Trial Of Hypertension Candidate
August 10, 2022
Tickers
LEXX
From Benzinga
Lexaria Bioscience' Tech Processed Cannabidiol Receives Positive FDA Feedback For Hypertension
August 10, 2022
Tickers
LEXX
From Benzinga
From Benzinga
Lexaria's DehydraTECH CBD Hypertension Study Dosing Complete With No Serious Adverse Events
July 27, 2022
From Benzinga
67 Biggest Movers From Yesterday
June 22, 2022
From Benzinga
Nasdaq Rises 2.5%; ACADIA Pharmaceuticals Shares Plummet
June 21, 2022
From Benzinga
From Benzinga
45 Stocks Moving In Tuesday's Mid-Day Session
June 21, 2022
From Benzinga
Lexaria Bioscience (NASDAQ: LEXX) Secures Patent For DehydraTECH To Deliver Antivirals
April 22, 2022
From Benzinga
53 Biggest Movers From Yesterday
April 21, 2022
From Benzinga
From Benzinga
28 Stocks Moving In Wednesday's Mid-Day Session
April 20, 2022
From Benzinga
51 Biggest Movers From Thursday
April 18, 2022
From Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
April 14, 2022
From Benzinga
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.